Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
The working hypothesis is that the low HDL serum level predict favorable response to anti
 viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve
 the rate of sustained virologic response.
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection.
 Metabolic syndrome predicts negative treatment outcome in HCV infection.

 Aim: to assess the association between lipids components of the metabolic syndrome and
 sustained viral response (SVR).
Inclusion Criteria:

 -  Chronic HCV genotype 1 naive patients

 Exclusion Criteria:

 -  Co infection with HBV, HIV, HDV

 -  Decompensated liver disease